Status:
RECRUITING
Conservative Treatment of PAS With or Without IIL
Lead Sponsor:
Tanta University
Conditions:
Placenta Accreta
Cesarean Hysterectomy
Eligibility:
FEMALE
20-35 years
Phase:
NA
Brief Summary
In the current study, the investigators aimed to compare the benefits of internal iliac ligation in placenta accreta spectrum
Detailed Description
This randomized control trial will be conducted at Tanta University hospital, Egypt, from 2022 to 2024. Tanta University Hospital is considered the main tertiary hospital at the center of Nile Delta ....
Eligibility Criteria
Inclusion
- Age under 35 years old.
- Prenatally diagnosed placenta accreta .
- Planned caesarean section ≤ 37 wks .
- ≤ previous 3 ceserian sections .
- Placenta accretta spectrum grade 1 , 2 ,3 .
- Patients who want to preserve their fertility.
- Patients who refuse hysterectomy .
Exclusion
- Cases with high risk of intraoperative blood loss as hemorrhagic disorders and thrombocytopenia .
- Cases on anticoagulant therapy.
- Patients who completed her family.
- Hemodynamicaly unstable patients.
- Finally cases who refused to get enrolled in the study.
Key Trial Info
Start Date :
May 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2024
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT05232981
Start Date
May 1 2022
End Date
October 1 2024
Last Update
February 28 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ayman Dawood
Tanta, Egypt